Integra LifeSciences Holdings CorporationIART stock score: 43/100
$13.55 · -2.24% · Scored Nov 19, 2026
- Technical
- 34
- Fundamental
- 46
- News
- —
The reading
Integra LifeSciences Holdings (IART) scores 43 out of 100, which reads weak, higher than 32% of Healthcare stocks and 30% of the 4,118 US stocks we score.
The composite weights fundamentals 80% and technicals 20%: fundamentals read 46, technicals 34.
Among the fundamentals, Earnings Growth (Quarterly) at 100 and Forward P/E at 97 score highest, while Earnings Quality (Yearly) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 41 and contrarian oscillators 50.
Since Aug 23, 2026 the composite has ranged from 31 to 45, and it is up 2 points over the period.
About Integra LifeSciences Holdings
Integra LifeSciences (IART) is a medical technology company that makes products for neurosurgery, ear, nose and throat procedures, surgical instruments and wound reconstruction. Its Specialty Surgery segment, formerly called Codman Specialty Surgical, sells dural grafts and sealants, cerebrospinal fluid management devices, intracranial pressure monitors, tissue ablation systems and cranial stabilization equipment used by neurosurgeons, along with ENT products and surgical instruments. Its Tissue Reconstruction segment, formerly called Tissue Technologies, sells regenerative tissue products, skin substitutes and other biologic and synthetic materials used to treat complex wounds, burns and surgical reconstruction. Customers include hospitals, surgery centers and distributors worldwide. Integra earns money from product sales, and many of its products are used repeatedly in procedures, providing steady demand. It has been working to fix manufacturing quality problems at several of its facilities, which led to product holds.
Integra competes with Medtronic, B. Braun and other neurosurgery suppliers, and with Smith+Nephew, Organogenesis and MiMedx in wound reconstruction. Its edge rests on long-established brands in neurosurgery, a broad portfolio that surgeons use in many procedures and expertise in regenerative tissue technology. Investors who follow IART stock tend to watch organic revenue growth in each segment and the progress of its manufacturing quality remediation. Product supply and the restart of products placed on hold are closely followed. Gross margins, regulatory inspections, debt levels and leadership changes are other factors.
What’s driving the score
The strongest and weakest of the scorers that count toward IART’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
46Pulling it up
Net income growth against the same quarter a year earlier, weighted toward the latest quarter.
Forward P/E ratio uses estimated future earnings to calculate valuation.
Current assets divided by current liabilities: the ability to pay short-term bills.
Holding it back
How reliably yearly earnings grow: the share of years with higher earnings, the compound growth rate, how steady that growth is, and the last two yearly changes.
5-year earnings growth evaluates long-term profit trajectory and consistency.
Return on Equity (ROE) measures how efficiently a company generates profits from shareholder equity.
38 weighted scorers; 1 had no data today and are left out rather than counted as zero.
Technical · daily
39Pulling it up
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
Performance versus SPY compares the stock's returns to the S&P 500 index.
Know Sure Thing (KST) combines multiple rate-of-change calculations to identify long-term trend reversals.
Holding it back
Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.
Where the close sits against its 100-day SMA.
Simple Moving Average (100-period) provides a longer-term perspective on price trends.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 38 | 1 |
| Daily | 39 | 3 |
| Weekly | 30 | 2 |
| Monthly | 30 | 2 |
| Quarterly | 33 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Nov 19, 2026 | 43 |
| Nov 18, 2026 | 44 |
| Nov 17, 2026 | 43 |
| Nov 16, 2026 | 44 |
| Nov 15, 2026 | 45 |
| Nov 14, 2026 | 45 |
| Nov 13, 2026 | 45 |
| Nov 12, 2026 | 43 |
| Nov 11, 2026 | 42 |
| Nov 10, 2026 | 41 |
| Nov 8, 2026 | 36 |
| Nov 7, 2026 | 36 |
| Nov 6, 2026 | 36 |
| Nov 5, 2026 | 40 |
| Nov 4, 2026 | 42 |
| Nov 3, 2026 | 39 |
| Nov 2, 2026 | 38 |
| Nov 1, 2026 | 36 |
| Oct 30, 2026 | 35 |
| Oct 29, 2026 | 35 |
| Oct 28, 2026 | 33 |
| Oct 27, 2026 | 33 |
| Oct 26, 2026 | 33 |
| Oct 25, 2026 | 32 |
| Oct 24, 2026 | 32 |
| Oct 23, 2026 | 32 |
| Oct 22, 2026 | 31 |
| Oct 21, 2026 | 33 |
| Oct 20, 2026 | 35 |
| Oct 19, 2026 | 35 |
| Oct 18, 2026 | 34 |
| Oct 17, 2026 | 34 |
| Oct 16, 2026 | 33 |
| Oct 15, 2026 | 35 |
| Oct 14, 2026 | 34 |
| Oct 13, 2026 | 37 |
| Oct 12, 2026 | 36 |
| Oct 11, 2026 | 36 |
| Oct 10, 2026 | 36 |
| Oct 9, 2026 | 36 |
| Oct 8, 2026 | 35 |
| Oct 7, 2026 | 34 |
| Oct 6, 2026 | 34 |
| Oct 5, 2026 | 35 |
| Oct 4, 2026 | 34 |
| Oct 3, 2026 | 34 |
| Oct 2, 2026 | 34 |
| Oct 1, 2026 | 40 |
| Sep 30, 2026 | 41 |
| Sep 29, 2026 | 43 |
| Sep 28, 2026 | 42 |
| Sep 27, 2026 | 41 |
| Sep 26, 2026 | 41 |
| Sep 25, 2026 | 42 |
| Sep 24, 2026 | 42 |
| Sep 23, 2026 | 41 |
| Sep 22, 2026 | 42 |
| Sep 21, 2026 | 39 |
| Sep 20, 2026 | 38 |
| Sep 19, 2026 | 38 |
| Sep 18, 2026 | 38 |
| Sep 17, 2026 | 38 |
| Sep 16, 2026 | 40 |
| Sep 15, 2026 | 40 |
| Sep 14, 2026 | 38 |
| Sep 13, 2026 | 39 |
| Sep 12, 2026 | 39 |
| Sep 11, 2026 | 38 |
| Sep 10, 2026 | 38 |
| Sep 9, 2026 | 40 |
| Sep 8, 2026 | 41 |
| Sep 7, 2026 | 40 |
| Sep 6, 2026 | 40 |
| Sep 5, 2026 | 40 |
| Sep 4, 2026 | 40 |
| Sep 3, 2026 | 40 |
| Sep 2, 2026 | 42 |
| Sep 1, 2026 | 42 |
| Aug 31, 2026 | 41 |
| Aug 30, 2026 | 42 |
| Aug 29, 2026 | 42 |
| Aug 28, 2026 | 42 |
| Aug 27, 2026 | 42 |
| Aug 26, 2026 | 42 |
| Aug 25, 2026 | 41 |
| Aug 24, 2026 | 41 |
| Aug 23, 2026 | 41 |
Key facts
- Market cap
- $1.1B
- Sector
- Healthcare
- Industry
- Medical Devices
- Beta
- 1.28
- Risk grade (1–10)
- 2
- Next earnings
- Oct 21, 2026
Medical Device peers
| Company | Market cap | Score |
|---|---|---|
| NVCR NovoCure | $1.2B | 44 |
| TNDM Tandem Diabetes Care | $1.2B | 38 |
| SIBN SI-BONE | $1.1B | 59 |
| ATEC Alphatec | $1.1B | 52 |
| IRMD IRADIMED | $1.0B | 66 |
| CBLL CeriBell | $1.0B | 51 |
Questions
What is IART's stock rating today?
IART scores 43/100 (Weak) as of Nov 19, 2026: technical 34, fundamental 46. Scores are recomputed every night.
What does Integra LifeSciences Holdings do?
Integra LifeSciences (IART) is a medical technology company that makes products for neurosurgery, ear, nose and throat procedures, surgical instruments and wound reconstruction. Its Specialty Surgery segment, formerly called Codman Specialty Surgical, sells dural grafts and sealants, cerebrospinal fluid management devices, intracranial pressure monitors, tissue ablation systems and cranial stabilization equipment used by neurosurgeons, along with ENT products and surgical instruments.
Is IART stock a buy?
The score is not a buy or sell recommendation. A 43 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the IART score calculated?
100 weighted scorers feed it today: 38 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.
Embed this score
A badge for a blog post, newsletter or README. It updates every night and links back here. More badges
HTML
<a href="https://stocksscores.com/stocks/iart/"><img src="https://stocksscores.com/stocks/iart/badge.svg" alt="IART stock score" height="20"></a>
Markdown
[](https://stocksscores.com/stocks/iart/)